U.S. Markets closed

Pharma Buying Spree Continues As AbbVie Takes Out Allergan For $63 Billion

ALLISON GATLIN
Pharma Buying Spree Continues As AbbVie Takes Out Allergan For $63 Billion

AbbVie is buying Botox-maker Allergan in a $63 billion deal, the pharma giant announced Tuesday — sending Allergan stock rocketing. The deal comes as AbbVie's Humira faces biosimilars.